IP Group, the developer of intellectual property based businesses, has welcomed the decision by Oxford Nanopore Technologies, a spin-out company from the University of Oxford, that it intends to commercialise DNA strand sequencing products directly to customers during this year.
IP Group has a 21.5% beneficial stake in Oxford Nanopore, which is developing a novel technology for direct, electronic detection and analysis of single molecules using nanopores.
At 10:33am: (LON:IPO) IP2IPO Group share price was +1.75p at 90p
SharePrice.com will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. All share prices are provided by the London Stock Exchange, and are at least 15 minutes delayed.